Olympus invests $ 35 million in Quebec

construction-nouveau-complexe-olympus-superficie(Quebec) The scarcity of labor does not frighten the multinational Olympus completes private investment of $ 35 million for the construction of a new complex in Quebec City.

On the contrary. It is precisely because of the quality and availability of talent Olympus (sales of US $ 7 billion and 31,000 employees worldwide) intends to continue its growth in the capital.

“Universities and CEGEPs form by highly competent employees,” pleaded Monday Olympus NDT Canada President and Chief Operating Officer Fabrice Cancre, during a press conference held at the City Hall in Quebec City with Mayor Régis Labeaume and Minister responsible for the Capitale-Nationale, Sam Hamad.

“Yes, it’s a challenge to find labor. I think it is a challenge everywhere. The competition is strong. At Olympus, we want to be a model employer in the region and we are investing to prove it, “added Mr. Dunce.

Having already set up shop in the Quebec Metro High Tech Park where it leases a building owned by Cominar, the high-tech company specialized in optical design and manufacture of advanced NDT technologies will move up shop at few blocks away. Specifically in the new Espace Innovation Michelet where another multinational, ABB, erects a building for $ 20 million.

To consolidate its 380 employees working in Quebec City and Lévis – Olympus NDT Canada has acquired certain assets of Mecnov in January 2014 – a new manufacturing plant and new administrative offices, the Japanese company acquired a plot of 33,000 square meters at a cost of $ 2.5 million.

The construction of the new complex with an area of ​​16,000 square meters will begin before the arrival of winter and should be completed in summer 2017. The project includes the erection of a factory and a center machining on one level, the development of a training center, a center for demonstration and validation of new products and spaces for employees, including a gym.

One hundred new jobs should be created in the wake of this investment of $ 35 million.

“The construction of this new building – it will be the largest Olympus Canada office – demonstrates our commitment to the Quebec City region and allow us to safely carry our growth plan for the next five years,” said Mr. Dunce. “The quality of the education system and labor is the main reason why we chose to build the new plant in Quebec,” he insisted.

“This major investment in Quebec Olympus reconfirms the economic benefits of our city that is distinguished by knowledge, research and innovation, especially by the creativity and quality of the skilled labor that is a major attraction for high-tech companies, “said for his part, the mayor of Quebec City, Régis Labeaume.

“The fact that Olympus has chosen to invest and build its new facility in Quebec is another demonstration of the economic vitality of the Capitale-Nationale”, welcomed Minister Hamad revealing that the technology sector Information and Communications and that of electronic products grouped together in the National Capital, 17,000 jobs in 560 companies whose turnover was $ 3.5 billion.

A parallel with Medicago
By participating in the announcement of Olympus, Mayor Régis Labeaume could not help but draw a parallel with Medicago, another small Quebec company became a subsidiary of a multinational.

Recall that in 2005, Olympus had got hold of RD Tech Québec for the sum of more than $ 115 million. RD Tech made its mark across the world in the manufacture of ultrasonic testing NDT for cracks in the great works in the fields of petrochemicals and energy, among others.

Originally called Trecad RD Tech, a company founded by Alain Allard in the mid 80s.

At the time, Régis Labeaume was working within the Société Innovatech Québec and Chaudière-Appalaches. “We funded this company had only two employees, has he recalled. Now reaping the benefits of these investments in technology innovation. ”

Today subsidiary of the Japanese pharmaceutical company Mitsubishi Tanabe Pharma, Medicago, a Quebec manufacturer of plant-based vaccines, had had similar humble beginnings to those Trecad / RD Tech.

Last May, the Japanese company announced it would invest $ 245 million for the construction of a new vaccine production complex in the capital, specifically in the Estimauville Innovation Area. No less than 200 new jobs are to be created.

Pamper yourself multinationals have subsidiaries in the region is also one of economic development strategies developed by the Québec International.

The Stopru